US2951540A
(en)
|
1956-11-05 |
1960-09-06 |
Gen Motors Corp |
Propeller brake
|
US3709898A
(en)
|
1971-02-09 |
1973-01-09 |
Upjohn Co |
Process for the production of triazolobenzodiazepines and intermediates
|
US3681343A
(en)
|
1971-05-11 |
1972-08-01 |
Upjohn Co |
6-phenyl-s-triazolo{8 4,3-a{9 {8 1,4{9 {0 benzodiazepines
|
US3812259A
(en)
|
1971-08-09 |
1974-05-21 |
Upjohn Co |
Animal feed and process
|
CH622019A5
(en)
|
1975-10-23 |
1981-03-13 |
Upjohn Co |
Process for the preparation of aminotriazolobenzodiazepines
|
FR2329668A1
(fr)
|
1975-10-27 |
1977-05-27 |
Upjohn Co |
Procede de preparation d'aminotriazolobenzodiazepines
|
EP0087850A1
(en)
|
1982-01-04 |
1983-09-07 |
The Upjohn Company |
Benzodiazepines for anti-hypertensive use
|
DE3435973A1
(de)
|
1984-10-01 |
1986-04-10 |
Boehringer Ingelheim KG, 6507 Ingelheim |
Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
|
DE3724164A1
(de)
|
1986-07-25 |
1988-01-28 |
Boehringer Ingelheim Kg |
Neue 1,4-benzodiazepine, ihre herstellung und verwendung
|
ATE86256T1
(de)
|
1987-05-28 |
1993-03-15 |
Yoshitomi Pharmaceutical |
Thieno(triazolo)diazepinverbindungen, und medizinische verwendung derselben.
|
JPH0676326B2
(ja)
|
1988-05-24 |
1994-09-28 |
吉富製薬株式会社 |
循環器系疾患治療薬
|
EP0368175A1
(de)
|
1988-11-06 |
1990-05-16 |
Boehringer Ingelheim Kg |
3S,7S-3-(Morpholinocarbonyl)-5-(2-chlorphenyl)-7,10-dimethyl-3,4-dihydro-2H,7H-cyclopenta[4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin.
|
EP0387613A1
(de)
|
1989-03-03 |
1990-09-19 |
Boehringer Ingelheim Kg |
Neue Thienodiazepine
|
YU133090A
(sh)
|
1989-07-12 |
1993-10-20 |
Boehringer Ingelheim Kg. |
Novi heteroazepini s paf-antaganostičnim učinkom in postopek za njihovo pripravo
|
DE4010528A1
(de)
|
1990-04-02 |
1991-10-17 |
Boehringer Ingelheim Kg |
Praeparativ chromatographisches trennverfahren zur herstellung enantiomerenreiner hetrazepine
|
CA2120939A1
(en)
|
1991-10-11 |
1993-04-15 |
Tetsuya Tahara |
Therapeutic agent for osteoporosis and diazepine compound
|
EP0661284A1
(en)
|
1992-09-18 |
1995-07-05 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Thienodiazepine compound and medicinal use thereof
|
WO1994022872A1
(en)
|
1993-03-30 |
1994-10-13 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Cell adhesion inhibitor and thienotriazolodiazepine compound
|
WO1995032963A1
(fr)
|
1994-06-01 |
1995-12-07 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Compose de thienylazole et compose de thienotriazolodiazepine
|
ES2159714T3
(es)
|
1995-01-06 |
2001-10-16 |
Hoffmann La Roche |
Hidroximetil-imidazodiazepinas y sus esteres.
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
MX9709875A
(es)
*
|
1995-06-06 |
1998-03-31 |
Pfizer |
N-(indol-2-carbonil)-glicinamidas substituidas y derivados como inhibidores de glicogeno fosforilasa, composiciones que las contienen y uso de las mismas.
|
WO1996039385A1
(en)
*
|
1995-06-06 |
1996-12-12 |
Pfizer Inc. |
Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
|
WO1997009048A1
(en)
|
1995-09-09 |
1997-03-13 |
F. Hoffmann-La Roche Ag |
Use of a thienotriazolodiazepine to increase apolipoprotein a-i levels
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
EP0934940A1
(en)
|
1996-06-12 |
1999-08-11 |
Japan Tobacco Inc. |
Cytokine production inhibitors, triazepine compounds, and intermediates thereof
|
US5693641A
(en)
|
1996-08-16 |
1997-12-02 |
Berlex Laboratories Inc. |
Bicyclic pyrimidine derivatives and their use as anti-coagulants
|
ES2182108T3
(es)
|
1996-09-13 |
2003-03-01 |
Mitsubishi Pharma Corp |
Compuestos de tienotriazolodiazepina y usos medicinales de los mismos.
|
US6444664B1
(en)
|
1997-04-18 |
2002-09-03 |
Nederlandse Organisatie Voor Toegepast - Natuurweten Schappelijk Onderzoek (Tno) |
Method for controlling the plasma level of lipoproteins to treat alzheimeris disease
|
JPH11228576A
(ja)
|
1997-12-10 |
1999-08-24 |
Japan Tobacco Inc |
アポトーシス抑制剤
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
FR2779652B1
(fr)
*
|
1998-06-15 |
2001-06-08 |
Sod Conseils Rech Applic |
Utilisation de diazepines pour la preparation de medicaments destines a traiter les etats pathologiques ou les maladies dans lesquels un des recepteurs de la somatostatine est implique
|
KR20000016732A
(en)
|
1998-12-12 |
2000-03-25 |
Japan Tobacco Inc |
Cytokine production inhibitors, triazepine compounds, and intermediates thereof
|
CA2373815A1
(en)
|
1999-05-14 |
2000-11-23 |
Imclone Systems Incorporated |
Treatment of refractory human tumors with epidermal growth factor receptor antagonists
|
US6312215B1
(en)
|
2000-02-15 |
2001-11-06 |
United Technologies Corporation |
Turbine engine windmilling brake
|
US7589167B2
(en)
|
2000-02-22 |
2009-09-15 |
J. David Gladstone Institutes |
ZA loops of bromodomains
|
EP1297836A4
(en)
|
2000-06-16 |
2007-06-13 |
Mitsubishi Pharma Corp |
COMPOSITIONS FOR CHECKING RELEASE, PH AREA AND / OR SPEED
|
WO2002002557A2
(en)
|
2000-06-30 |
2002-01-10 |
Neurogen Corporation |
2-phenylimidazo[1,2-a]pyridine derivatives: a new class of gaba brain receptor ligands
|
US20060142257A1
(en)
|
2001-01-19 |
2006-06-29 |
Eberhard Nieschlag |
Male contraceptive formulation comprising norethisterone
|
US6979682B2
(en)
|
2001-02-23 |
2005-12-27 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Platelet-activating factor antagonist inhibition of angiogenesis and tumor growth induced by basic fibroblast
|
US20030216758A1
(en)
|
2001-12-28 |
2003-11-20 |
Angiotech Pharmaceuticals, Inc. |
Coated surgical patches
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
US6861422B2
(en)
|
2003-02-26 |
2005-03-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
KR20050106465A
(ko)
|
2003-02-27 |
2005-11-09 |
아보트 러보러터리즈 |
헤테로사이클릭 키나제 억제제
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
AU2004251654A1
(en)
|
2003-06-02 |
2005-01-06 |
Icoria, Inc. |
Use of genes differentially expressed during aging of liver for treatment and diagnosis
|
WO2005002526A2
(en)
|
2003-07-01 |
2005-01-13 |
President And Fellows Of Harvard College |
Method and compositions for treatment of viral infections
|
EP1663992A1
(en)
|
2003-09-18 |
2006-06-07 |
Novartis AG |
2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
|
EP1528056A1
(en)
|
2003-10-29 |
2005-05-04 |
Academisch Ziekenhuis bij de Universiteit van Amsterdam |
Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
|
US7759485B2
(en)
|
2004-08-14 |
2010-07-20 |
Boehringer Ingelheim International Gmbh |
Process for the manufacture of dihydropteridinones
|
US20060074088A1
(en)
|
2004-08-14 |
2006-04-06 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones for the treatment of cancer diseases
|
US20060058311A1
(en)
|
2004-08-14 |
2006-03-16 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation
|
US20060035903A1
(en)
|
2004-08-14 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Storage stable perfusion solution for dihydropteridinones
|
CN1759834B
(zh)
|
2004-09-17 |
2010-06-23 |
中国医学科学院医药生物技术研究所 |
黄连素或其与辛伐他汀联合在制备用于预防或治疗与血脂有关疾病或症状的产品中用途
|
US8624027B2
(en)
|
2005-05-12 |
2014-01-07 |
Abbvie Inc. |
Combination therapy for treating cancer and diagnostic assays for use therein
|
US8044042B2
(en)
|
2005-05-30 |
2011-10-25 |
Mitsubishi Tanabe Pharma Corporation |
Thienotriazolodiazepine compound and medicinal use thereof
|
JP2009503014A
(ja)
|
2005-08-03 |
2009-01-29 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
呼吸器系疾患の治療におけるジヒドロプテリジノン
|
US8133900B2
(en)
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
US8604042B2
(en)
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
NZ592990A
(en)
|
2005-11-01 |
2013-01-25 |
Targegen Inc |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
AR058505A1
(es)
|
2005-11-04 |
2008-02-06 |
Wyeth Corp |
Combinaciones antineoplasicas de temsirolimus y malato de sunitinib
|
MX2008008320A
(es)
|
2005-12-23 |
2008-09-03 |
Smithkline Beecham Corp |
Inhibidores de azaindol de aurora cinasas.
|
RU2426732C2
(ru)
|
2006-01-17 |
2011-08-20 |
Ф. Хоффманн-Ля Рош Аг |
АРИЛ-ИЗОКСАЗОЛ-4-ИЛ-ИМИДАЗО[1,2-a]ПИРИДИН, ПРИГОДНЫЙ ДЛЯ ЛЕЧЕНИЯ БОЛЕЗНИ АЛЬЦГЕЙМЕРА ЧЕРЕЗ ПОСРЕДСТВО GABA-РЕЦЕПТОРОВ
|
JP5243970B2
(ja)
|
2006-02-14 |
2013-07-24 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
タンパク質キナーゼの阻害剤として有用なジヒドロジアゼピン
|
US20070218135A1
(en)
|
2006-03-14 |
2007-09-20 |
Glenmark Pharmaceuticals Limited |
Sustained release matrix pharmaceutical composition
|
JP2009535425A
(ja)
|
2006-05-03 |
2009-10-01 |
ノバルティス アクチエンゲゼルシャフト |
有機化合物の使用
|
US7621117B2
(en)
|
2006-06-19 |
2009-11-24 |
Pratt & Whitney Canada Corp. |
Apparatus and method for controlling engine windmilling
|
EP2078016B1
(en)
|
2006-10-19 |
2012-02-01 |
Signal Pharmaceuticals LLC |
Heteroaryl compounds, compositions thereof, and methods of treatment therewith
|
US8338464B2
(en)
|
2006-11-30 |
2012-12-25 |
Albert Einstein College Of Medicine Of Yeshiva University |
Small molecule inhibitors of BCL6
|
KR101810348B1
(ko)
|
2006-12-26 |
2017-12-18 |
랜티우스 메디컬 이메징, 인크. |
심장 신경 분포의 영상화를 위한 리간드
|
JP2008156311A
(ja)
|
2006-12-26 |
2008-07-10 |
Institute Of Physical & Chemical Research |
Brd2ブロモドメイン結合剤
|
WO2008137081A1
(en)
|
2007-05-02 |
2008-11-13 |
The Trustees Of Columbia University In The City Of New York |
Substituted ( 5, 6 ) -dihydronaphraalenyl compounds as reversible male contraceptives
|
KR20080107050A
(ko)
|
2007-06-05 |
2008-12-10 |
울산대학교 산학협력단 |
항-cd137 단일클론 항체를 포함하는 만성이식편대숙주 질환의 예방 또는 치료용 약학적 조성물
|
EP2234986A2
(en)
|
2007-12-20 |
2010-10-06 |
Cellzome Limited |
Sulfamides as zap-70 inhibitors
|
WO2009084692A1
(ja)
*
|
2007-12-28 |
2009-07-09 |
Nippon Telegraph And Telephone Corporation |
可変焦点レンズ
|
WO2009084693A1
(ja)
|
2007-12-28 |
2009-07-09 |
Mitsubishi Tanabe Pharma Corporation |
抗癌剤
|
US20110098288A1
(en)
|
2008-03-11 |
2011-04-28 |
Jeremy Major |
Sulfonamides as zap-70 inhibitors
|
WO2010015340A1
(en)
|
2008-08-06 |
2010-02-11 |
Bayer Schering Pharma Aktiengesellschaft |
Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment
|
ES2448567T3
(es)
|
2008-10-30 |
2014-03-14 |
Circomed Llc |
Derivados de la tienotriazoldiazepina activos en apo A
|
JP5908728B2
(ja)
|
2009-01-06 |
2016-04-26 |
ダナ ファーバー キャンサー インスティテュート インコーポレイテッド |
ピリミド−ジアゼピノンキナーゼ骨格化合物及び疾患を治療する方法
|
US7928105B2
(en)
|
2009-01-23 |
2011-04-19 |
Takeda Pharmaceutical Company Limited |
Substituted 6a,7,8,9-tetrahydropyrido[3,2-e]pyrrolo[1,2-a]pyrazin-6(5H)-ones
|
GB0919431D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
GB0919423D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
GB0919434D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
ES2564318T3
(es)
|
2009-11-05 |
2016-03-21 |
Glaxosmithkline Llc |
Inhibidor de bromodominio de benzodiazepina
|
AU2010314395B2
(en)
|
2009-11-05 |
2015-04-09 |
Glaxosmithkline Llc |
Benzodiazepine bromodomain inhibitor
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
GB0919426D0
(en)
*
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
US8862173B2
(en)
|
2009-12-10 |
2014-10-14 |
Motorola Solutions, Inc. |
Method for selecting media for delivery to users at an incident
|
EP2536725B1
(en)
|
2010-02-17 |
2015-10-28 |
Boehringer Ingelheim International GmbH |
Dihydropteridinones, method for production and use thereof
|
EP2553251B1
(en)
|
2010-03-26 |
2018-11-07 |
Rolls-Royce North American Technologies, Inc. |
Adaptive fan system for a variable cycle turbofan engine
|
HUE031073T2
(en)
|
2010-05-14 |
2017-06-28 |
Dana Farber Cancer Inst Inc |
Thieno triazolo-diazepine compounds for the treatment of neoplasia
|
JP5715241B2
(ja)
|
2010-05-14 |
2015-05-07 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法
|
EP2569434B1
(en)
|
2010-05-14 |
2019-09-04 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating leukemia and related disorders
|
WO2011143651A1
(en)
*
|
2010-05-14 |
2011-11-17 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating metabolism
|
US9301962B2
(en)
|
2010-05-14 |
2016-04-05 |
Baylor College Of Medicine |
Male contraceptive compositions and methods of use
|
ES2526671T3
(es)
|
2010-06-22 |
2015-01-14 |
Glaxosmithkline Llc |
Compuestos de benzotriazoldiazepina inhibidores de bromodominios
|
JP6073783B2
(ja)
|
2010-06-25 |
2017-02-01 |
シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド |
ヘパランn−スルファターゼのcns送達のための方法および組成物
|
US20120014979A1
(en)
|
2010-07-16 |
2012-01-19 |
Alexander Dent |
Use of bcl6 inhibitors for treating autoimmune diseases
|
TWI549955B
(zh)
|
2010-08-04 |
2016-09-21 |
達納 法柏癌症學院有限公司 |
治療腫瘤形成、發炎疾病及其他病症之組成物及方法
|
CN103228142A
(zh)
*
|
2010-09-28 |
2013-07-31 |
加利福尼亚大学董事会 |
治疗代谢综合征相关疾病的gaba激动剂和治疗或预防i型糖尿病的gaba组合
|
US9249161B2
(en)
|
2010-12-02 |
2016-02-02 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
US20130004481A1
(en)
|
2011-01-12 |
2013-01-03 |
Boehringer Ingelheim International Gmbh |
Anticancer therapy
|
EP2677865A4
(en)
|
2011-02-23 |
2015-04-22 |
Icahn School Med Mount Sinai |
BROMODOMAIN INHIBITORS AS MODULATORS OF GENE EXPRESSION
|
JP2014511389A
(ja)
|
2011-02-28 |
2014-05-15 |
エピザイム インコーポレイテッド |
置換6,5−縮合二環式ヘテロアリール化合物
|
EP2741784B1
(en)
|
2011-03-02 |
2017-05-17 |
Board Of Regents, The University Of Texas System |
Tusc2 therapies
|
JP2014524409A
(ja)
|
2011-07-29 |
2014-09-22 |
ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア |
Hivの治療のための組成物および方法
|
FI20110279A0
(fi)
|
2011-08-29 |
2011-08-29 |
Outotec Oyj |
Menetelmä metallien talteenottamiseksi niitä sisältävästä materiaalista
|
WO2013033269A1
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bioorthogonal monomers capable of dimerizing and targeting bromodomains and methods of using same
|
WO2013033268A2
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bivalent bromodomain ligands, and methods of using same
|
US10071129B2
(en)
|
2011-08-30 |
2018-09-11 |
Whitehead Institute For Biomedical Research Dana-Farber Cancer Institute, Inc. |
Method for identifying bromodomain inhibitors
|
DE102011082013A1
(de)
|
2011-09-01 |
2013-03-07 |
Bayer Pharma AG |
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
|
WO2013097052A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbott Laboratories |
Bromodomain inhibitors
|
CN104203267A
(zh)
|
2012-02-17 |
2014-12-10 |
安迅生物制药公司 |
用于治疗流感和副流感患者的方法、化合物和组合物
|
WO2013148197A1
(en)
|
2012-03-28 |
2013-10-03 |
The J. David Gladstone Institutes |
Compositions and methods for reactivating latent immunodeficiency virus
|
US9763956B2
(en)
|
2012-06-19 |
2017-09-19 |
The Broad Institute, Inc. |
Diagnostic and treatment methods in subjects having or at risk of developing resistance to cancer therapy
|
CN104968334B
(zh)
|
2012-09-28 |
2018-09-14 |
翁科埃斯克斯有限公司 |
包含噻吩并三唑并二氮杂卓化合物的药物制剂
|
US9567301B2
(en)
|
2012-11-02 |
2017-02-14 |
Dana-Farber Cancer Institute, Inc. |
Pyrrol-1-yl benzoic acid derivatives useful as myc inhibitors
|
US20160009725A1
(en)
|
2013-02-22 |
2016-01-14 |
Bayer Pharma Aktiengesellschaft |
Pyrrolo- and pyrazolo-triazolodiazepines as bet-protein inhibitors for treating hyperproliferative diseases
|
CN105164135A
(zh)
|
2013-02-22 |
2015-12-16 |
拜耳医药股份有限公司 |
4-取代的吡咯并二氮杂卓和吡唑并二氮杂卓
|
CA2902225A1
(en)
|
2013-02-28 |
2014-09-04 |
Washington University |
Methods of treatment of human cytomegalovirus infection and diseases with bromodomain inhibitors
|
US9714946B2
(en)
|
2013-03-14 |
2017-07-25 |
Dana-Farber Cancer Institute, Inc. |
Bromodomain binding reagents and uses thereof
|
BR112015023184A2
(pt)
|
2013-03-15 |
2017-11-21 |
Constellation Pharmaceuticals Inc |
método para o tratamento de uma doença, inibidor e seu uso, composição, método de identificação de um composto e método para inibir a produção de il-4, il-5 e il-13
|
CA2913741A1
(en)
|
2013-05-28 |
2014-12-04 |
The Brigham And Women's Hospital, Inc. |
Bet inhibition therapy for heart disease
|
DE102013106353B4
(de)
|
2013-06-18 |
2018-06-28 |
Tdk Corporation |
Verfahren zum Aufbringen einer strukturierten Beschichtung auf ein Bauelement
|
KR20160034379A
(ko)
|
2013-07-25 |
2016-03-29 |
다나-파버 캔서 인스티튜트 인크. |
전사 인자의 억제제 및 그의 용도
|
WO2015018522A1
(en)
|
2013-08-06 |
2015-02-12 |
Oncoethix Sa |
Bet-bromodomain inhibitor shows synergism with several anti-cancer agents in pre-clinical models of diffuse large b-cell lymphoma (dlbcl)
|
KR20160037201A
(ko)
|
2013-08-06 |
2016-04-05 |
온코에틱스 게엠베하 |
Bet-브로모도메인 억제제를 사용한 미만성 거대 b-세포 림프종 (dlbcl)의 치료 방법
|
WO2015023938A1
(en)
|
2013-08-16 |
2015-02-19 |
Rana Therapeutics, Inc. |
Epigenetic regulators of frataxin
|
US8988212B2
(en)
|
2013-08-22 |
2015-03-24 |
GM Global Technology Operations LLC |
Electric vehicle pedestrian warning system
|
JP6663852B2
(ja)
|
2013-09-19 |
2020-03-13 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
Bh3プロファイリングの方法
|
WO2015054642A2
(en)
|
2013-10-11 |
2015-04-16 |
Genentech, Inc. |
Use of cbp/ep300 bromodomain inhibitors for cancer immunotherapy
|
WO2015070020A2
(en)
|
2013-11-08 |
2015-05-14 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy for cancer using bromodomain and extra-terminal (bet) protein inhibitors
|
WO2015081284A1
(en)
|
2013-11-26 |
2015-06-04 |
Coferon, Inc. |
Bivalent bromodomain ligands, and methods of using same
|
CA2936865A1
(en)
|
2014-01-31 |
2015-08-06 |
Dana-Farber Cancer Institute, Inc. |
Diaminopyrimidine benzenesulfone derivatives and uses thereof
|
WO2015117083A1
(en)
|
2014-01-31 |
2015-08-06 |
Dana-Farber Cancer Institute, Inc. |
Diazepane derivatives and uses thereof
|
EP3099693A4
(en)
|
2014-01-31 |
2017-08-16 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
AU2015222805B2
(en)
|
2014-02-28 |
2020-05-21 |
Tensha Therapeutics, Inc. |
Treatment of conditions associated with hyperinsulinaemia
|
BR112017008714A2
(pt)
|
2014-10-27 |
2017-12-19 |
Tensha Therapeutics Inc |
inibidores de bromodomínio
|
CA2969417A1
(en)
|
2014-12-05 |
2016-06-09 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Bromodomain inhibitor as adjuvant in cancer immunotherapy
|
MA42249A
(fr)
|
2015-06-26 |
2018-05-02 |
Tensha Therapeutics Inc |
Traitement de carcinome de la ligne médiane nut
|
JP2018530554A
(ja)
|
2015-10-02 |
2018-10-18 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
ブロモドメイン阻害薬及びチェックポイント阻害薬による併用療法
|